Key Takeaway
Meta-analysis of 47,000+ adults showing that more daily steps are associated with progressively lower mortality risk, with benefits plateauing around 8,000-10,000 steps for older adults.
Summary
This landmark meta-analysis pooled data from 15 studies involving 47,471 adults to establish the dose-response relationship between daily step count and all-cause mortality.
Key findings showed that mortality risk decreased progressively with higher step counts, with the most dramatic benefits occurring between 4,000-8,000 steps. For adults 60+, benefits plateaued around 6,000-8,000 steps, while younger adults continued to see benefits up to 8,000-10,000 steps.
Importantly, stepping intensity (cadence) had no significant association with mortality after adjusting for total daily steps, suggesting that total volume matters more than speed.
Methods
- Meta-analysis of 15 international prospective cohort studies
- 47,471 adults followed for average of 7 years
- Step counts measured via accelerometer
- Stratified analysis by age (<60 vs. 60+)
- Adjusted for confounders (age, sex, BMI, health behaviors)
Key Results
- Each 1,000-step increase associated with 6-15% lower mortality
- Adults <60: 8,000-10,000 steps showed optimal benefit
- Adults 60+: 6,000-8,000 steps showed optimal benefit
- No upper limit where more steps increased risk
- Step intensity not significant after adjusting for total steps
Figures
Figure 1
Figure 2
Figure 3
Limitations
- Observational data (cannot prove causation)
- Single time-point step measurement
- Heterogeneity across study populations
- Healthy participant bias possible